Clinical Research

The National Institute of Allergies and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), announced this week that the fourth iteration of the COVID-19 Adaptive Treatment Study (ACTT-4)...

Making effective use of decentralized clinical trials (DCTs) could help diversify patient populations, create new study opportunities for sites, and improve the quality of surgeries, says Dr. Pamela Tenaerts, who has...

"Systemic racism is as real as any disease," said Rebecca Marklund recently on a PhRMA blog. “Diversifying clinical trials is a critical avenue for change, and PhRMA and its members are...

For decades it was thought that the power of the placebo effect resided in the belief that patients were receiving, or at least could receive, pharmacologically active treatment. A new study...

The COVID-19 pandemic has proven the clinical trial industry can rally quickly to develop vaccines in record time. Remote surveillance of study sites may also have been shown to persist. "Remote...

Even with access to a clinical trial, cancer patients living in the poorest areas of America are nearly 30% more likely to die from their disease than the richest patients, according...

The Center for Information and Study on Participation in Clinical Research (CISCRP), a non-profit organization dedicated to engaging the public and patients as partners in the clinical research process, has announced...

Social distancing and bans may have reduced the spread of COVID-19, but researchers at Penn State College of Medicine also report that these measures may have adversely affected clinical researchers' ability...

A new survey conducted by researchers from Georgetown, Rutgers, Johns Hopkins and 1Day Sooner shows that the vast majority of the nearly 2,000 potential COVID-19 volunteer subjects interviewed are motivated by...

New research from the University of Virginia Cancer Center (UVA) could save once promising immunotherapies for the treatment of solid cancer tumors such as ovarian, colon and triple negative breast cancers...